Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Recurso digital |
| Jezik: | |
| Izdano: |
Zenodo
2025
|
| Teme: | |
| Online dostop: | https://doi.org/10.5281/zenodo.17977466 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
Kazalo:
- Fosfomycin, often as part of a combination therapy, appears effective against carbapenem-resistant Acinetobacter species, though monotherapy is likely inadequate due to intrinsic resistance. Combination regimens improve clinical outcomes and microbiological eradication.